StockData

Paysign vs Repay

PAYS and RPAY side by side, both in miscellaneous business services. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How PAYS and RPAY compare

Paysign is the larger company, worth 1.5 times as much as Repay ($539M against $364M).

Paysign grew revenue faster over the last twelve months (46.8% versus 8.8% for Repay).

Paysign keeps more of each dollar of sales as profit, with a net margin of 15.7% compared with −49.6% at Repay.

Paysign scores higher on the StockData Score (15 against 5 for Repay), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricPAYSRPAY
Size and price
Market cap$539M$364M
Share price$9.54$4.05
Change, 1 year74.4%15.7%
Change, 5 years387%−76.3%
Beta (5Y)0.021.42
Employees80486
StockData Score
Total score15 (better)5
Valuation score33
Growth score5 (better)1
Performance score4 (better)0
Health score3 (better)1
Dividend score00
Valuation
P/E36.7×–
P/S5.4×1.1× (better)
P/B9.0×0.8× (better)
EV/EBITDA19.5×–
P/FCF7.3×3.3× (better)
PEG0.42–
FCF yield13.6%30.3% (better)
Fair value$9.79$10.15
Margin of safety2.6%60.1% (better)
Growth
Revenue growth (TTM)46.8% (better)8.8%
Revenue growth, 5Y average27.7% (better)14.8%
Net income growth (TTM)133%–
EPS growth (TTM)117%–
Profitability
Gross margin61.0%73.5% (better)
Operating margin17.0% (better)−44.2%
Net margin15.7% (better)−49.6%
FCF margin73.0% (better)32.6%
Return on equity30.8% (better)−30.3%
Return on invested capital35.2% (better)−11.2%
Financial health
Debt / equity0.09 (better)1.59
Net debt / EBITDA−0.84–
Interest coverage–−7.6×
Current ratio1.141.45 (better)
Altman Z-score2.01 (better)−0.39
Piotroski F-score7 (better)4
Dividends and buybacks
Buyback yield0.00%–
Shareholder yield0.00%0.00%
Ownership
Held by institutions53.6%80.1%
Held by insiders53.5%46.5%
Insider net buying, 12 months−$8.4M$13.0M (better)
Short interest, % of float9.3%7.7%

Go deeper

For information only, not investment advice. Check the source filings before relying on any figure.